Investment Summary

Eight Roads Invests In Ashish Life Science

On January 31, 2019, private equity firm Eight Roads invested in life science company Ashish Life Science

Investment Highlights
  • This is Eight Roads’ 54th transaction in the Life Science sector.
  • This is Eight Roads’ 29th transaction in India.

Investment Summary

Date 2019-01-31
Target Ashish Life Science
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target

Ashish Life Science

Mumbai, India
Ashish Life Science is an export-focussed generic veterinary pharmaceuticals company. Ashish Life Science was founded in 1975 and is based in Mumbai, Maharashtra.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 206 of 293
Sector: Life Science M&A 54 of 73
Type: Venture M&A Deals 183 of 266
Country: India M&A 29 of 37
Year: 2019 M&A 5 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-21 Caplin Steriles

Chennai, India

Caplin Steriles is a developer of injectable pharmaceutical products that caters to the rapidly growing demand for injectable products in the regulated markets, especially the US and Europe. Caplin Steriles was founded in 2018 and is based in Chennai, Tamil Nadu.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-01 Arvelle Therapeutics

Zug, Switzerland

Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland.

Buy -